11 Teams Selected from the Future Committee
Support Provided from Company Matching to Prototyping and Technology Transfer

Seoul St. Mary's Hospital announced on January 30 that the Mustard Seed Growth Center, which it jointly operates with the Catholic Educational Foundation, will actively promote its commercialization track with a target of 2026. The center held a launch ceremony on the previous day, January 29, to mark the beginning of the first cohort of the commercialization track.

Participants are taking a commemorative photo at the launch ceremony of the Mustard Seed Growth Center Commercialization Track. Seoul St. Mary's Hospital

Participants are taking a commemorative photo at the launch ceremony of the Mustard Seed Growth Center Commercialization Track. Seoul St. Mary's Hospital

View original image

Since its opening in February 2021, the Mustard Seed Growth Center has been running the "Innovation and Startup Idea Contest" to discover innovative ideas and foster talent in the healthcare sector. After the contest, the center has supported further development of ideas through the "Future Committee" system, offering consulting, mentoring, education, and networking opportunities.


However, there have been concerns about the lack of institutional support when moving from idea discovery to actual product development and commercialization. By launching this new commercialization track, the center has established a practical support system that connects teams with companies and supports prototype production. The plan is to enhance the operational structure by running a two-track strategy alongside the existing contest track.


Eleven teams, selected from among the third to fifth cohorts of the Future Committee based on their commercialization potential, are participating in the commercialization track. Starting with the launch ceremony, the center will begin the company matching process and plans to support research and development with the goal of participating in the "2026 International Hospital and Health Tech Fair (KHF)" in August and achieving technology transfer.


In the third cohort, "ZeroD," which is developing a dental anti-aspiration device, is participating. The fourth cohort includes "PsignalS," which is developing a detachable bed and pole fixing device; "Kollok," a wearable device for cough measurement; and "Nursevation," which is developing nursing supplies.


The fifth cohort participating teams include "Smooth," a rail-type sliding tool for patient transfer; "Easy-ABGA," an ultrasound-based automatic arterial blood gas sampling device; "Originals," an AI-based home palliative care nurse program; "CAUTI-ZERO," a wheelchair-mounted urine bag case; "TalkTalk," an AI agent supporting communication for medical staff; "LuckyViki," a nursing supplies developer; and "Fastriage," an emergency room severity classification algorithm.


Company matching will be handled by Dcircle, a startup that provides an AI-based industry-academia-research collaboration matching service. Dcircle operates a platform that uses artificial intelligence and big data to promote research achievements and match R&D partners.


The Mustard Seed Growth Center aims to build an execution-driven startup model centered on internal talent and ideas through the commercialization track, accelerating outcomes in prototype production and technology transfer. Through these efforts, the center plans to establish an internal culture of innovation and secure differentiated growth engines.


Father Jisang Sul, Chair of the Center's Operations Committee, stated, "We will review institutional improvements and expand support so that the commercialization track can become a model for innovation ecosystems in the medical field."



The Mustard Seed Growth Center, together with the 11 teams of the first cohort, has designated 2026 as the "Year of Full-Scale Commercialization" and plans to publicly showcase its achievements at the KHF Fair in August.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing